74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Zimmer Biomet Holdings Inc
Closed
Sector Healthcare
104.77 1.09
Overview
Share price change
24h
Min
104.06
Max
104.98
Income | 249M |
|---|---|
Sales | 1.8B |
P/E Sector Avg | 23.327 73.394 |
EPS | 2.31 |
Dividend yield | 0.93 |
Profit margin | 13.661 |
EBITDA | 533M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +15.28 upside |
Dividend yield Sector Avg | 0.93% 3.09% |
|---|---|
Next Earnings | 1 May 2025 |
Next Dividend date | 29 Apr 2025 |
Next Ex Dividend date | 27 Mar 2025 |
Market Cap | -1.9B 21B |
|---|---|
Previous open | 103.68 |
Previous close | 104.77 |
News Sentiment
By Acuity
56%
44%
317 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Bullish Evidence
Zimmer Biomet Holdings Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Zimmer Biomet Holdings Inc Forecast
Price Target
By TipRanks
15.28% upside
12 Months Forecast
Average 120.85 USD 15.28%
High 140 USD
Low 107 USD
Based on 21 Wall Street analysts offering 12 month price targets forZimmer Biomet Holdings Inc - Dist in the last 3 months.
Sentiment
By Acuity
317 / 393 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
